Jump to content

Angiozyme

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by RileyBot (talk | contribs) at 23:05, 22 February 2013 (→‎External links: Bot: Updating URL for www.cancer.gov per site update) (Task 7). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Angiozyme is a substance that is being studied in the treatment of kidney cancer. It may prevent the growth of blood vessels from surrounding tissue to the tumor. It belongs to the families of drugs called VEGF receptor and angiogenesis inhibitors. Also called RPI.4610.

External links

  • Angiozyme entry in the public domain NCI Dictionary of Cancer Terms

Public Domain This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.

Stub icon

This oncology article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Angiozyme&oldid=539775705"